🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.39
-1.03 (-1.68%)
Nov 20, 2026, 4:00 PM EST - Market closed

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had revenue of $1.02B in the quarter ending September 30, 2026, with 32.02% growth. This brings the company's total for the last twelve months to $3.66B, up 18.14% year-over-year. In the year 2025, BioMarin Pharmaceutical had annual revenue of $3.22B with 12.87% growth. That makes BioMarin Pharmaceutical the 3,316th largest company in the world by revenue and 941st in the United States.

Revenue (ttm)
$3.66B
Revenue Growth
+18.14%
P/S Ratio
3.22
Revenue / Employee
$1,134,780
Employees
3,221
Market Cap
11.70B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • VOXZOGO 926.92M 28.8%
  • VIMIZIM 792.05M 24.6%
  • NAGLAZYME 485.40M 15.1%
  • PALYNZIQ 433.31M 13.5%
  • ALDURAZYME 208.51M 6.5%
  • BRINEURA 186.40M 5.8%
  • KUVAN 99.53M 3.1%
  • Other 89.13M 2.8%

By Geography

Chart
  • United States 1.10B 34.3%
  • Europe 874.33M 27.1%
  • Rest of World 544.47M 16.9%
  • Latin America 435.48M 13.5%
  • Other 208.51M 6.5%
  • Royalty and Other 53.49M 1.7%
Fiscal year ended Dec 31, 2025 See the full BioMarin Pharmaceutical breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.22B367.34M12.87%
Dec 31, 20242.85B434.69M17.97%
Dec 31, 20232.42B323.19M15.42%
Dec 31, 20222.10B249.76M13.53%
Dec 31, 20211.85B-14.18M-0.76%
Dec 31, 20201.86B156.41M9.18%
Dec 31, 20191.70B212.84M14.27%
Dec 31, 20181.49B177.57M13.52%
Dec 31, 20171.31B196.79M17.62%
Dec 31, 20161.12B226.96M25.50%
Dec 31, 2015889.90M140.61M18.77%
Dec 31, 2014749.28M200.80M36.61%
Dec 31, 2013548.49M47.76M9.54%
Dec 31, 2012500.72M59.37M13.45%
Dec 31, 2011441.36M65.09M17.30%
Dec 31, 2010376.27M51.61M15.90%
Dec 31, 2009324.66M28.16M9.50%
Dec 31, 2008296.49M172.82M139.74%
Dec 31, 2007123.67M39.46M46.86%
Dec 31, 200684.21M58.54M228.06%
Dec 31, 200525.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.